Skip to content
10-K

Annual Report

Nuvation Bio Inc. NUVB

0000950170-25-034903

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Gross Profit FY 2024 · Dec 31, 2024 $795K
Gross Profit FY 2024 · Dec 31, 2023 $0
Cost Of Revenue FY 2024 · Dec 31, 2024 $7.08M
Cost Of Revenue FY 2024 · Dec 31, 2023 $0
Shares Diluted FY 2024 · Dec 31, 2023 218.88K sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$68M
Short Term Debt FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2023 $42.65M
Current Liabilities FY 2024 · Dec 31, 2023 $13.97M
Total Liabilities FY 2024 · Dec 31, 2023 $16.36M
Current Assets FY 2024 · Dec 31, 2023 $616.43M
Total Assets FY 2024 · Dec 31, 2023 $621.48M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.35
Eps Basic FY 2024 · Dec 31, 2023 −$0.35
Sga Expense FY 2024 · Dec 31, 2023 $28.53M
Rd Expense FY 2024 · Dec 31, 2023 $71.29M
Net Income FY 2024 · Dec 31, 2023 −$75.8M
Operating Income FY 2024 · Dec 31, 2023 −$99.82M
Revenue FY 2024 · Dec 31, 2023 $0
Stockholders Equity FY 2024 · Dec 31, 2022 $655.08M